Early research (Phase 1)Study completedNCT00055705What this trial is testingPV701 in Treating Patients With Advanced or Recurrent Peritoneal CancerWho this might be right forCancer Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00550654What this trial is testingConformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the BrainWho this might be right forKidney CancerMelanoma (Skin)Metastatic Cancer+3 more National Institutes of Health Clinical Center (CC) 1
Large-scale testing (Phase 3)UnknownNCT00954174What this trial is testingPaclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity CancerWho this might be right forMixed Mesodermal (Mullerian) TumorOvarian CarcinosarcomaRecurrent Fallopian Tube Carcinoma+39 more GOG Foundation 637
Testing effectiveness (Phase 2)Study completedNCT00004066What this trial is testingGemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue SarcomaWho this might be right forOvarian CancerSarcomaSmall Intestine Cancer Memorial Sloan Kettering Cancer Center 82
Not applicableStudy completedNCT00258401What this trial is testingLow-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.Who this might be right forCervical CancerDiarrheaProstate Cancer+2 more Case Comprehensive Cancer Center 11
Large-scale testing (Phase 3)Active Not RecruitingNCT03914612What this trial is testingTesting the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial CancerWho this might be right forEndometrial Clear Cell AdenocarcinomaEndometrial Dedifferentiated CarcinomaEndometrial Endometrioid Adenocarcinoma+13 more National Cancer Institute (NCI) 813
Testing effectiveness (Phase 2)Study completedNCT00003657What this trial is testingHigh-dose ICE With AmifostineWho this might be right forBladder CancerBrain and Central Nervous System TumorsCarcinoma of Unknown Primary+8 more Dana-Farber Cancer Institute 24
Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Large-scale testing (Phase 3)UnknownNCT01087268What this trial is testingHyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic CancerWho this might be right forBladder CancerCervical CancerColorectal Cancer+9 more Royal Marsden NHS Foundation Trust 75
Not applicableStudy completedNCT00295945What this trial is testingEpidural Analgesia or Patient-Controlled Analgesia in Treating Patients Who Have Undergone Surgery for Gynecologic CancerWho this might be right forCervical CancerEndometrial CancerFallopian Tube Cancer+4 more University of California, San Francisco 240
Large-scale testing (Phase 3)Study completedNCT00003212What this trial is testingIfosfamide or Doxorubicin in Treating Patients With Advanced or Metastatic Soft Tissue SarcomaWho this might be right forSarcoma European Organisation for Research and Treatment of Cancer - EORTC 780
Early research (Phase 1)Study completedNCT00842452What this trial is testingTopotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by SurgeryWho this might be right forCervical CancerEndometrial CancerFallopian Tube Cancer+4 more Steven Waggoner, MD 26
Testing effectiveness (Phase 2)Ended earlyNCT00033644What this trial is testingCombination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the UterusWho this might be right forSarcoma Gynecologic Oncology Group
Early research (Phase 1)Study completedNCT01155258What this trial is testingTemsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsWho this might be right forExtensive Stage Small Cell Lung CancerHereditary ParagangliomaMale Breast Cancer+45 more University of Southern California 19
Not applicableStudy completedNCT00433407What this trial is testingT-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid TumorsWho this might be right forBreast CancerLung CancerOvarian Cancer+3 more Jonsson Comprehensive Cancer Center 12
Not applicableWithdrawnNCT00499291What this trial is testingPaclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid TumorsWho this might be right forCancer Eastern Cooperative Oncology Group
Early research (Phase 1)Study completedNCT00004241What this trial is testing17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or SarcomaWho this might be right forAIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaAnaplastic Large Cell Lymphoma+50 more National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT00003778What this trial is testingDolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue SarcomaWho this might be right forOvarian CancerSarcoma National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Study completedNCT00227669What this trial is testingGemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue LeiomyosarcomaWho this might be right forSarcoma UNICANCER 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07576725What this trial is testingLow Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO TrialWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+40 more Fred Hutchinson Cancer Center 50